INVESTOR RELATIONS
ABOUT THE COMPANY
genXone company is active in the biotechnology industry and offers nucleic acid (DNA and RNA) sequencing services based on the innovative nanopore sequencing technology, Next-Generation Sequencing (NGS), also known as third-generation sequencing.
The company is the first in Poland to be accredited and licensed for commercial use of the nanopore sequencing technology developed by Oxford Nanopore Technologies (ONT). Based on the access to ONT technology, the company creates its own, new solutions in the form of laboratory protocols as well as bioinformatics tools, scripts and algorithms, enabling the use of nanopore sequencing in many areas of science and business, including in genetic diagnostics, food industry, veterinary medicine and agriculture. The experienced team of genXone, which consists of specialists in the field of molecular genetics and bioinformatics, works on modern solutions. The activity of genXone is complemented by the Molecular Diagnostics Laboratory, which conducts research using the Real-Time PCR method, including the detection and quantification of pathogens in various human systems.
COMPANY’S DATA
Name
genXone S.A.
Country
Polska
Headquarters
Złotniki
Address
ul. Kobaltowa 6, 62-002 Złotniki
KRS number
362943497
NIP
7811918132
Court
Sąd Rejonowy Poznań Nowe Miasto i Wilda w Poznaniu, VIII Wydział Gospodarczy Krajowego Rejestru Sądowego
REGON
362943497
Telephone
LISTING
On the 25th of August 2020, genXone S.A was welcomed to the floor of the NewConnect market.
genXone S.A. was the 374th NewConnect listed company on the debut date and the 8th debut on the market in 2020.

THE BOARD & THE SUPERVISORY BOARD
The Board
Michał Kaszuba – President
The main originator, co-founder of the company, innovator and entrepreneur; a graduate of the University of Warmia and Mazury in Olsztyn (Faculty of Biology) and the Institute of Genetics and Animal Breeding of the Polish Academy of Sciences (doctor of agricultural sciences). He has extensive experience in the implementation of research and development projects in the field of biology and genetics. He has been honored and awarded many times for his achievements. Michał Kaszuba is the winner of the Marshal of the Wielkopolska Province Award in the Micro Future category (2007) and two-time finalist of the well-known Ernst & Young Entrepreneur of the Year competition in the New Business category (2009 and 2010).
Anna Strumnik – Vicepresident
Doctor of Medicine, specialist in medical laboratory diagnostics, and medical immunology. Graduate of the Medical University of Białystok, where she earned a PhD in Medical Sciences. She also completed postgraduate studies in human resources management. She gained experience in some of the largest laboratory chains in Poland.
The Supervisory Board
Janusz Kraśniak – Member of the Supervisory Board
An Associate Professor at Poznan University of Economics and a Secretary & Member-Supervisory Board at Blumerang Investors SA. He is on the Board of Directors at Arena.pl SA, GenXone SA and Blumerang Investors SA. Mr. Krasniak was previously employed as a Member of the Supervisory Board of Inno Gene SA
Career history:
2012-2016 member of the Supervisory Board of INNO-GENE SA.
2011-2014 professor at the Wyższa Szkoła Handlu i Usług in Poznań
2007 – secretary of the Supervisory Board of Blumerang Investors SA.
2005 – secretary and member of the board of the Poznań Branch of the Scientific Society of Organization and Management.
2003-2011 lecturer at the Wyższa Szkoła Kupiecka in Konin.
2003 – Head of Postgraduate Studies in Organization and Management at the Poznań University of Economics.
2001-2003 lecturer at the Wyższa Szkoła Bankowa in Poznań
1992 – associate professor at the Department of Strategic Management at the Wyższa Szkoła Handlu i Usług in Poznań
1991 – professional officer at the Agricultural Market Research and Services Office of Bank Wielkopolski S.A. in Poznań.
Supervisory and/or management functions performed over the last 3 years:
2013-2023 member of the Supervisory Board ofArena SA
2023 – nadal member of the Supervisory Board of Hipower Energy SA
independence criterion met: YES
Mariusz Koitka – Member of the Supervisory Board
A graduate of the University of Economics in Poznań in the field of Economic Cybernetics and IT, specialization Data Processing and Accounting, graduated in 1991. In addition, he completed a course in the implementation of a modern financial controlling system in small and medium-sized enterprises for advisors in the field of public trading in securities, and as part of the study practical implementation of controlling course. Mr. Koitka has also completed numerous training courses organized by banks in the field of assessment of the financial situation of enterprises, accounting and valuations
Career history:
2023-2024 Quantum Asset Management Sp. z o.o. – President of the Management Board
2022 – present Bamos S.A. – President of the Management Board.
2018 – present genXone S.A. – Member of the Supervisory Board.
2017 – 2019 – Blu Asset Management Sp. z o.o. – President of the Management Board.
2016 – 2020 – Opieka i Zaufanie S.A. – Member of the Supervisory Board.
2015 – present – Medcamp S.A. – Member of the Supervisory Board.
2011 – Woodwaste Sp. z o.o. – Vice President of the Management Board and STL Sp. z o.o. – President of the Management Board.
2009 – 2011 – Woodwaste Sp. z o.o. – Chief Financial Officer.
2007 – 2008 – AgroBiznes Sp. j. – Economic and Financial Director.
2006–2007 – Deutsche Bank PBC S.A. – Corporate Client Advisor.
2004–2006 – BGŻ S.A. – Institutional Client Advisor.
2002–2004 – Bank Zachodni WBK S.A. – Business Advisor.
1998–2000 – Zakłady Farmaceutyczne Biowet S.A. in Gorzów Wielkopolski – Financial Advisor to the President of the Management Board, Financial Advisor.
1997–1998 – Packaging Printing House Jangraf S.A. in Gorzów Wielkopolski – Controlling Manager.
1997 – BGŻ Regional Branch in Gorzów Wielkopolski – Deputy Chief Accountant.
1992 – 1997 – Gospodarczy Bank Spółdzielczy in Gorzów Wielkopolski – successively Inspector, Specialist for Bank Assets and Liabilities Management, Specialist for Financial Management, Chief Specialist for Capital Management and Economic Analysis, Head of the Economic Analysis and IT Department.
Supervisory and/or management functions performed over the last 3 years:
2023-2024 Quantum Asset Management Sp. z o.o. – Member of the Management Board
since 2022 Bamos S.A. – President of the Management Board
since 2023
MR SUB 1 Sp. z o.o. – President of the Management Board
MR SUB 2 Sp. z o.o. – President of the Management Board
MR SUB 3 Sp. z o.o. – President of the Management Board
MR SUB 4 Sp. z o.o. – President of the Management Board
MR SUB 5 Sp. z o.o. – President of the Management Board
MR SUB 6 Sp. z o.o. – President of the Management Board
MR SUB 7 Sp. z o.o. – President of the Management Board
MR SUB 8 Sp. z o.o. – President of the Management Board
MR SUB 9 Sp. z o.o. – President of the Management Board
MR SUB Admin i Prom Sp. z o.o. – President of the Management Board
MR SUB Development 1 Sp. z o.o. – President of the Management Board
Unirox sp. zo.o. – President of the Management Board
MR SUB 1 Sp. z o.o. S.K.A. – President of the Management Board of the General Partner
MR SUB 1 Sp. z o.o. ALFA S.K.A.- President of the Management Board of the General Partner
MR SUB 1 Sp. z o.o. BETA S.K.A.- President of the Management Board of the General Partner
MR SUB 1 Sp. z o.o. Gamma S.K.A.- President of the Management Board of the General Partner
MR SUB 3 Sp z o.o. sp. k. – President of the Management Board of the General Partner
independence criterion met: YES
Piotr Ciżkowicz – Member of Supervisory Board
A graduate of Warsaw School of Economics in Warsaw. In 2016 he earned his D.Sc. degree (habilitation). From 1998 to 2000 he was an assistant of the Minister of Finance. He is the author of many domestic and foreign scientific publications in the field of public finance, monetary policy and applied econometrics as well as columns in the daily press.
2022-2023 Member of Supervisory Board MPAY S.A.
2021 – Member of Supervisory Board Livekid sp. z o.o.
2020 – Member of Supervisory Board genXone S.A.
July 2020 – The Board President StatXplorer sp. z o.o. (earlier: NUNATAK CAPITAL ADVISORS sp. z o.o.)
February 2020 – Managing Partner Nunatak Capital Sp z o.o.
2019-2021 Member of Supervisory Board (since 2020 Chairman of the Supervisory Board) RADPOL S.A.
2018 – 2022 Member of Supervisory Board (since 2019 Chairman of the Supervisory Board) Herkules S.A.
2018 – Member of Supervisory Board MWiK in Bydgoszcz
2016-2018 Board Member Luma Investment S.A.
2016 – TSB Partners (now: Nunatak Partners)
2016-2018 Vice-Chairman of the Supervisory Board Bydgoski Park Przemysłowo – Technologiczny
2012-2015 Board Member Polskie Koleje Państwowe S.A.
Supervisory and/or management functions performed over the last 3 years::
Nunatak Capital ZASI sp z o.o. – President – od 2019 r.
StatXplorer Sp z o.o. – President – od 2019 r.
MWiK Bydgoszcz S. A. – Member of Supervisory Board – od 2018
Pergamin sp zo.o. – Member of Supervisory Board – od 2020 r.
LiveKid Sp z o o – Member of Supervisory Board – od 2021 r.
MPay S.A. – Member of Supervisory Board – 2021-2022
independence criterion met: NO
Jakub Swadźba – Member of the Supervisory Board
A graduate of the Medical Academy of M. Copernicus (currently Collegium Medicum of the Jagiellonian University) in 1990. Habilitated doctor of medical sciences (2013), specialist in internal diseases. Author of numerous scientific papers on autoimmune diseases. Mr. Jakub Swadzba is a Chairman-Management Board at Diagnostyka Sp zoo, a Member-Founders Board at Fundacja Akademia Nowoczesniej Diagnostyki, a Member-Management Board at Diagnostyka Turcja Sp zoo, a Member-Management Board at Oncogene Diagnostics Sp zoo and a Vice Chairman-Management Board at genXone SA. He is on the Board of Directors at Genomed SA, Abp Investments Sp zoo, Genomtec SA, House-Med Sp zoo, Platforma Badan Genetycznych Sp zoo and Regenmed Sp zoo. He received his doctorate degree from Uniwersytet Jagiellonski Collegium Medicum.
independence criterion met: NO
Dariusz Zowczak – Member of the Supervisory Board
A graduate of the Medical Academy of M. Copernicus (currently Collegium Medicum of the Jagiellonian University) in 1990. Habilitated doctor of medical sciences (2013), specialist in internal diseases. Author of numerous scientific papers on autoimmune diseases. Mr. Jakub Swadzba is a Chairman-Management Board at Diagnostyka Sp zoo, a Member-Founders Board at Fundacja Akademia Nowoczesniej Diagnostyki, a Member-Management Board at Diagnostyka Turcja Sp zoo, a Member-Management Board at Oncogene Diagnostics Sp zoo and a Vice Chairman-Management Board at genXone SA. He is on the Board of Directors at Genomed SA, Abp Investments Sp zoo, Genomtec SA, House-Med Sp zoo, Platforma Badan Genetycznych Sp zoo and Regenmed Sp zoo. He received his doctorate degree from Uniwersytet Jagiellonski Collegium Medicum.
Since 2007, Vice President of the Management Board of Diagnostyka S.A.
independence criterion met: NO
Jolanta Kołodziejczyk – Member of the Supervisory Board
From 2003, she’s worked at Diagnostyka S.A., where recently has held the position of Deputy Sales Director. Until 2019, she was the President of the Management Boards of the largest Polish network of non-public pathomorphological institutes: Diagnostyka Consilio and Histamed Diagnostyka Consilio. In 2004-2009 she was the President of the Academy of Modern Diagnostics Foundation. She is a doctor of biological sciences. She graduated from the Jagiellonian University.
Career history:
since 2003 – Diagnostyka S.A:
2009 – 2023 deputy sales director
2023 –Director of Offer Development and Scientific Cooperation
(earlier in Diagnostyka Sp. zo.o.: Medical Representative, Marketing Manager, Director of the Scientific Information Department)
2023 – Instytut Mikroekologii sp. z o.o. – Vicepresident
2014-I 2022 Diagnostyka Consilio sp. z o.o., Diagnostyka Consilio spółka z ograniczoną odpowiedzialnością Poznań Sp.K., Histamed Diagnostyka Consilio spółka z ograniczoną odpwiedzialnością, Histamed DC sp. z o.o. – President
2022 – Diagnostyka Genesis sp. zo.o.- Vicepresident
2006-2009 www.labtestsonline.pl National Editor
2006-2019 Fundacja Akademia Nowoczesnej Diagnostyki, President
2004-2009 Bliżej Diagnostyki Editor-in-Chief
Supervisory and/or management functions performed over the last 3 years::
Diagnostyka Consilio sp. z o.o. President (2014.12.01-2022.01)
Diagnostyka Consilio spółka z ograniczoną odpowiedzialnością Poznań sp. k. President (2018.10.15-2022.01)
Histamed Diagnostyka Consilio spółka z o.o. sp. k. President (2019.08.13-2022.01)
Histamed DC sp. z o.o. President (since 2020.12.01) , coowner
Diagnostyka Genesis sp.zo.o. – Vicepresident (since 2022)
Instytut Mikroekologii sp. zo.o. – Vicepresident (since 2023)
GenXone S.A – Vicepresident (2022-2024)
Vet Cell Tech sp. z o.o. – Member of the Supervisory Board (since 2023)
independence criterion met: NO